(Q40036848)

16 September 2017

Treatment of patients with diabetes with GLP-1 analogues or DPP-4- inhibitors: a hot topic for cardiologists? (English)

1 reference

16 September 2017

Thomas Jax

1

1 reference

16 September 2017

13 October 2008

1 reference

Clinical Research in Cardiology

16 September 2017

1 reference

16 September 2017

98

1 reference

16 September 2017

2

1 reference

16 September 2017

75-79

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-008-0725-y

16 September 2017

0 references

cites work

Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure

1 reference

12 December 2020

Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.

1 reference

12 December 2020

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

1 reference

12 December 2020

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

1 reference

12 December 2020

Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure

1 reference

12 December 2020

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

1 reference

12 December 2020

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

1 reference

12 December 2020

Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride

1 reference

12 December 2020

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

1 reference

12 December 2020

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

1 reference

12 December 2020

High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography.

1 reference

12 December 2020

[Glucose control in cardiac disease]

1 reference

12 December 2020

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

1 reference

12 December 2020

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

1 reference

12 December 2020

GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery

1 reference

12 December 2020

Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium

1 reference

12 December 2020

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

1 reference

12 December 2020

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

1 reference

12 December 2020

Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats

1 reference

12 December 2020

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

12 December 2020

Screening for undiagnosed diabetes in patients with acute myocardial infarction

1 reference

12 December 2020

Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.

1 reference

12 December 2020

Cardiac function in mice lacking the glucagon-like peptide-1 receptor

1 reference

12 December 2020

Cardiac metabolism as a target for the treatment of heart failure

1 reference

12 December 2020

Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats

1 reference

12 December 2020

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

1 reference

12 December 2020

Effects of glucagon-like peptide-1 and long-acting analogues on cardiovascular and metabolic function

1 reference

12 December 2020

Distribution of GLP-1 and PACAP receptors in human tissues

1 reference

12 December 2020

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

1 reference

12 December 2020

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts

1 reference

12 December 2020

Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes

1 reference

12 December 2020

10.1007/S00392-008-0725-Y

Identifiers

DOI

1 reference

16 September 2017

1 reference

PubMed ID

18853087